Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Beck

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Genes & Development|November 16, 2012
The role of PR-Set7 in replication licensing depends on Suv4-20hDavid B Beck, Adam Burton, Hisanobu Oda, et al.
Molecular Cell|November 2, 2010
Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damageHisanobu Oda, Michael R Hübner, David B Beck, et al.
Lancet (London, England)|August 15, 2021
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosumNatasha Dehghan, Krista M Marcon, Tony Sedlic, et al.
Rheumatology (Oxford, England)|June 17, 2022
Novel genetic mutation in myositis-variant of VEXAS syndromeJames S Topilow, Daniela Ospina Cardona, David B Beck, et al.
JAAD Case Reports|August 2, 2021
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndromeFaris Alhomida, David B Beck, Tracy I George, et al.
The Journal of Allergy and Clinical Immunology|September 28, 2020
The systemic autoinflammatory diseases: Coming of age with the human genomeDeborah L Stone, David B Beck, Kalpana Manthiram, et al.
Science (New York, N.Y.)|April 2, 2011
The C-terminal domain of RNA polymerase II is modified by site-specific methylationRobert J Sims, Luis Alejandro Rojas, David B Beck, et al.
Clinical and Translational Medicine|June 6, 2019
The use of leukocytes' secretome to individually target biological therapy in autoimmune arthritis: a case reportPatrice E Poubelle, Nathalie Pagé, Marie-Pier Longchamps, et al.
Cell|October 2, 2012
Asymmetrically modified nucleosomesPhilipp Voigt, Gary LeRoy, William J Drury, et al.
Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Genes & Development|November 16, 2012
The role of PR-Set7 in replication licensing depends on Suv4-20hDavid B Beck, Adam Burton, Hisanobu Oda, et al.
Molecular Cell|November 2, 2010
Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damageHisanobu Oda, Michael R Hübner, David B Beck, et al.
Lancet (London, England)|August 15, 2021
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosumNatasha Dehghan, Krista M Marcon, Tony Sedlic, et al.
Rheumatology (Oxford, England)|June 17, 2022
Novel genetic mutation in myositis-variant of VEXAS syndromeJames S Topilow, Daniela Ospina Cardona, David B Beck, et al.
JAAD Case Reports|August 2, 2021
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndromeFaris Alhomida, David B Beck, Tracy I George, et al.
The Journal of Allergy and Clinical Immunology|September 28, 2020
The systemic autoinflammatory diseases: Coming of age with the human genomeDeborah L Stone, David B Beck, Kalpana Manthiram, et al.
Science (New York, N.Y.)|April 2, 2011
The C-terminal domain of RNA polymerase II is modified by site-specific methylationRobert J Sims, Luis Alejandro Rojas, David B Beck, et al.
Clinical and Translational Medicine|June 6, 2019
The use of leukocytes' secretome to individually target biological therapy in autoimmune arthritis: a case reportPatrice E Poubelle, Nathalie Pagé, Marie-Pier Longchamps, et al.
Cell|October 2, 2012
Asymmetrically modified nucleosomesPhilipp Voigt, Gary LeRoy, William J Drury, et al.
Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.
Pageof 9